Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML [Phase 1, Phase 2]
Phase 1/2 trial evaluating arsenic trioxide in combination with cytarabine for high-risk myelodysplastic syndrome and poor-prognosis acute m…
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis [Phase 3]
A Phase 3 trial comparing cyclophosphamide with methotrexate plus a calcineurin inhibitor for GVHD prophylaxis in patients with various hema…
-
FDA approval · 2017-02-27FDA Approved: DECITABINE — Original Application (Accord Healthcare Inc.)
FDA approves an original ANDA for decitabine by Accord Healthcare Inc., establishing a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation in young patients with acute myeloid leukemia, including cases with mono…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia [Phase 1]
Phase 1 trial evaluating low-dose total-body irradiation and fludarabine phosphate followed by an unrelated donor stem cell transplant in pa…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-17Clinical Trial Update: Alisertib for Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of alisertib for acute myeloid leukemia has completed.
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: Sulindac for Patients With AML [Phase 2]
The Phase 2 clinical trial of sulindac for acute myeloid leukemia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating the combination of tosedostat with cytarabine or decitabine in adults with newly diagnosed acute myeloid leukemia o…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Reflexology: An Intervention for Acute Myeloid Leukemia(AML) Patients [NA]
A clinical trial examining reflexology as an intervention for patients with Acute Myeloid Leukemia.
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: A Prospective, Interventional Study Assessing Response to Cytarabine, Daunorubicin and Etoposide (ADE) for First Relapse of Paediatric Acute Myeloid Leukemia [Phase 2]
A prospective Phase 2 interventional trial evaluating response to the ADE regimen (cytarabine, daunorubicin, and etoposide) for first relaps…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study evaluating therapeutic allogeneic lymphocytes with aldesleukin for high-risk or recur…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous cytokine-induced killer cell adoptive immunotherapy for acute myeloid leukemia and myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies [Phase 1, Phase 2]
Phase 1 and Phase 2 results are reported for allogeneic cytokine-induced killer (CIK) cell immunotherapy given to patients who relapsed afte…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating azacitidine in combination with lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Study of the Glutaminase Inhibitor CB-839 in Leukemia [Phase 1]
This document provides a Phase 1 trial update for CB-839, a glutaminase inhibitor, in patients with acute myeloid leukemia and acute lymphob…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients [Phase 2]
Phase 2 clinical trial evaluating the combination of cytarabine (Ara-C) and aclarubicin with pegylated G-CSF (PEG-G-CSF) as initial treatmen…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia [Phase 1]
Phase 1 pilot trial of lenalidomide in adult Diamond-Blackfan anemia patients with transfusion-dependent anemia. The study was terminated an…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP)
A completed prospective pilot study at West Virginia University analyzed bone marrow and peripheral blood from acute myeloid leukemia patien…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Idarubicin and High-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia [Phase 2]
This update summarizes the results of a Phase 2 clinical trial evaluating idarubicin with high-dose cytarabine in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]
Phase 3 trial evaluating daunorubicin, cytarabine, and midostaurin in newly diagnosed acute myeloid leukemia.
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML
Feasibility study evaluating intermediate-dose cytarabine (Ara-C) with autologous stem cell transplant as consolidation for low- to intermed…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia
This completed clinical trial analyzed factors associated with the development of severe sepsis in patients being treated for acute myeloid …